Antimicrobial Use in Hospitalised Patients with COVID-19: An International Multicentre Point-Prevalence Study

Studies suggest that the incidence of coinfections in patients with the coronavirus disease 2019 (COVID-19) is low, but a large number of patients receive antimicrobials during hospitalisation. This may fuel a rise in antimicrobial resistance (AMR). We conducted a multicentre point-prevalence survey...

Descripción completa

Detalles Bibliográficos
Autores principales: Papst, Lea, Luzzati, Roberto, Carević, Biljana, Tascini, Carlo, Gorišek Miksić, Nina, Vlahović Palčevski, Vera, Djordjevic, Zorana M., Simonetti, Omar, Sozio, Emanuela, Lukić, Milica, Stevanović, Goran, Petek, Davor, Beović, Bojana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868464/
https://www.ncbi.nlm.nih.gov/pubmed/35203779
http://dx.doi.org/10.3390/antibiotics11020176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868464/
https://www.ncbi.nlm.nih.gov/pubmed/35203779
http://dx.doi.org/10.3390/antibiotics11020176

Ejemplares similares